| Literature DB >> 35741058 |
Mathilde Coulet1,2, Oliver Kepp2,3, Guido Kroemer2,3,4, Stéphane Basmaciogullari1.
Abstract
As indicated by an ever-increasing number of FDA approvals, biotherapeutics constitute powerful tools for the treatment of various diseases, with monoclonal antibodies (mAbs) accounting for more than 50% of newly approved drugs between 2014 and 2018 (Walsh, 2018). The pharmaceutical industry has made great progress in developing reliable and efficient bioproduction processes to meet the demand for recombinant mAbs. Mammalian cell lines are preferred for the production of functional, complex recombinant proteins including mAbs, with Chinese hamster ovary (CHO) cells being used in most instances. Despite significant advances in cell growth control for biologics manufacturing, cellular responses to environmental changes need to be understood in order to further improve productivity. Metabolomics offers a promising approach for developing suitable strategies to unlock the full potential of cellular production. This review summarizes key findings on catabolism and anabolism for each phase of cell growth (exponential growth, the stationary phase and decline) with a focus on the principal metabolic pathways (glycolysis, the pentose phosphate pathway and the tricarboxylic acid cycle) and the families of biomolecules that impact these circuities (nucleotides, amino acids, lipids and energy-rich metabolites).Entities:
Keywords: immunotherapy; industrial production; metabolomics; monoclonal antibodies; process optimization
Mesh:
Substances:
Year: 2022 PMID: 35741058 PMCID: PMC9221972 DOI: 10.3390/cells11121929
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Figure 1Global view of the central CHO cell metabolism at the exponential phase of growth.
Amino acids and amino acid derivatives at the exponential phase.
| Amino Acid Derivative | Behavior | Reference | Comments |
|---|---|---|---|
| Alanine | Intracellular production and accumulation in media | [ | |
| Production mainly from cytosolic pyruvate | [ | ||
| Arginine | Intracellular consumption leading to concentration decrease in media | [ | Different conclusion might be due to feeding method and medium composition that is specific to [ |
| Accumulation from late-exponential phase onwards, indicating over-supply in the fed-batch | [ | ||
| Asparagine | Intracellular consumption leading to concentration decrease in media | [ | |
| The most consumed amino acid from media. Intracellular deamination to aspartic acid generates ammonia | [ | ||
| Consumption (measures performed on cell substrate). Represents 5% of incoming carbon source. Linked to aspartic acid production | [ | ||
| Intracellular concentration increase in early exponential phase | [ | ||
| Aspartic acid | Production linked to asparagine uptake (measures performed on cell substrate) | [ | |
| Consumption (measures performed on cell culture supernatant) | [ | ||
| Consumption (measures performed on cell substrate) | [ | ||
| Cysteine | Consumption (measures performed on cell culture supernatant) | [ | |
| Glutamine | Cells use more glutamine when cultivated in a media containing more glutamine | [ | |
| Consumption during all culture phases, with the highest during the exponential phase; source of lactate formation | [ | ||
| Main amino acid consumed | [ | ||
| Consumption linked to glutamic acid production | [ | ||
| Uptake from the media, the highest compared to other growth phases. In high producer clone, consumption beyond stoichiometric requirements together with asparagine to replenish the TCA intermediates | [ | ||
| Glutamic acid | Intracellular production leading to increased concentration in media | [ | |
| Production associated with glutamine uptake | [ | ||
| Glycine | Accumulation in media during culture | [ | The low uptake identified in [ |
| Accumulation in media during culture; produced by serine catabolism | [ | ||
| Low uptake from media | [ | ||
| Its accumulation in media together with the other identified metabolites leads to growth inhibition in HIPDOG culture | [ | ||
| Histidine | Uptake from media | [ | |
| Isoleucine | Uptake from media | [ | |
| Leucine | Uptake from media | [ | The particularity of study [ |
| Its accumulation in media together with the other identified metabolites leads to growth inhibition in HIPDOG culture | [ | ||
| Lysine | Uptake from media | [ | |
| Methionine | Uptake from media | [ | The particularity of study [ |
| Its accumulation together with the other identified metabolites leads to growth inhibition in HIPDOG culture | [ | ||
| Phenylalanine | Uptake from media | [ | The particularity of study [ |
| Its accumulation in media together with the other identified metabolites leads to growth inhibition in HIPDOG culture | [ | ||
| Proline | Accumulation in media | [ | In study [ |
| Slight increase in concentration in media with time | [ | ||
| Uptake from media | [ | ||
| Serine | An increase in the intracellular concentration during the early exponential phase | [ | The particularity of study [ |
| Uptake from media | [ | ||
| Its accumulation together with the other identified metabolites leads to growth inhibition in HIPDOG culture | [ | ||
| Threonine | Uptake from media | [ | |
| Tryptophan | Uptake from media | [ | The particularity of study [ |
| Depleted in media despite constant addition of feed | [ | ||
| Its accumulation together with the other identified metabolites leads to growth inhibition in HIPDOG culture | [ | ||
| Tyrosine | Uptake from media | [ | The particularity of study [ |
| Its accumulation together with the other identified metabolites leads to growth inhibition in HIPDOG culture | [ | ||
| Valine | Uptake from media | [ | |
|
|
|
|
|
| Aspartylphenylalanine | Accumulation in media; known to be toxic | [ | |
| Glutamylalanine | Accumulation in media | [ | |
| Glutamylphenylalanine | Accumulation in media; known to be detrimental to cell growth | [ | |
| Formylmethionine | Accumulating in media | [ | |
| 5-L-glutamyl-L-alanine | Accumulation in media | [ | |
| Dimethyl-L-arginine | Accumulation in media; associated with apoptosis | [ | |
| N-acetyl-L-Leucine | Accumulation in media | [ | |
| N-acetyl-L-phenylalanine | Accumulation in media; associated with apoptosis | [ | |
| N-acetylmethionine | Accumulation in media | [ | |
| N-formyl-L-methionine | Accumulation in media | [ | |
| L-homocysteine | Accumulation in media. Metabolic source is methionine. Its accumulation together with the other identified metabolites leads to growth inhibition in HIPDOG culture | [ | |
| 3-(4-Hydroxyphenyl) lactate | Accumulation in media. Metabolic sources are phenylalanine and tyrosine. Its accumulation together with the other identified metabolites leads to growth inhibition in HiPDOG culture | [ | |
| Phenyllactate | Accumulation in media. Metabolic source is phenylalanine. Its accumulation together with the other identified metabolites leads to growth inhibition in HiPDOG culture | [ | |
| Indole 3-lactate, indole-3-carboxylate, 2-hydroxyburtyrate, and 4-hydroxyphenylpyruvate | Accumulation in media. Metabolic source is tryptophan. Its accumulation together with the other identified metabolites leads to growth inhibition in HiPDOG culture | [ | |
| Isovalerate | Accumulation in media. Metabolic source is leucine. Its accumulation together with the other identified metabolites leads to growth inhibition in HiPDOG culture | [ | |
| Formate | Accumulation in media. Metabolic sources are serine, threonine and glycine. Its accumulation together with the other identified metabolites leads to growth inhibition in HiPDOG culture | [ | |
| Isobutyrate | Accumulation in media | [ | |
| Ammonia | Secreted in media during exponential and transition phase, with this being correlated with glutamine and asparagine consumption. Accumulation is known to affect productivity and inhibit cell growth | [ | |
| Ammonium | Intracellular and media accumulation mainly due to breakdown of glutamine and several amino acids; detrimental effects on growth presumably due to apoptosis induction | [ |
Amino acids and amino acid derivatives at the stationary phase.
| Amino Acid | Behavior | Reference | Comments |
|---|---|---|---|
| Alanine | Accumulation in media | [ | The switch observed in [ |
| Constant increase in concentration with time | [ | ||
| Switch from alanine secretion to uptake in media during stationary phase at the same time as aspartate and asparagine exhaustion | [ | ||
| Arginine | Intracellular level decreases during the stationary phase | [ | |
| Asparagine | Depleted at entry into stationary phase. Exponential growth and antibody production continue if it is added again in the media | [ | The asparagine concentrations used in these studies might be different, leading to its exhaustion at different times of the culture |
| Intracellular consumption. Represents 8% of incoming carbon source | [ | ||
| Uptake from the media, with this being lower than at exponential phase | [ | ||
| Aspartic acid | Below detection level once cells enter stationary phase. Exponential growth and antibody production resumes when added to media | [ | The aspartic acid concentrations used in these studies might be different, leading to its exhaustion at different times of the culture |
| Depleted in media during stationary phase | [ | ||
| Cysteine | Depletion at entry into stationary phase | [ | |
| Glutamine | Consumption | [ | The glutamine concentrations used in these studies might be different, leading to its exhaustion at different times of the culture |
| Depleted in media at entry in stationary phase | [ | ||
| Uptake from the media, with this being lower than at exponential phase | [ | ||
| Glutamic acid | Below detection level once cells enter stationary phase. Exponential growth and antibody production resumes when added to media | [ | The glutamic acid concentrations used in these studies might be different, leading to its exhaustion at different times of the culture |
| Constant detection | [ | ||
| Glycine | NA | ||
| Histidine | NA | ||
| Isoleucine | NA | ||
| Leucine | NA | ||
| Lysine | NA | ||
| Methionine | NA | ||
| Phenylalanine | Intracellular level dropped during stationary phase | [ | |
| Proline | Slight increase in concentration with time | [ | |
| Serine | Consumption from media | [ | |
| Threonine | Intracellular level decreases during stationary phase | [ | The particularity of study [ |
| Accumulation in media identified as growth inhibitor in HiPDOG culture | [ | ||
| Tryptophan | Intracellular level decreases during stationary phase | [ | |
| Increased availability in media correlates with diminished viable cell density and accumulation of an intermediate during tryptophan metabolism, 5-hydroxyindolacetaldehyde (5-HIAAld), which is suspected to be an inhibitor of cell growth | [ | ||
| Tyrosine | Depletion at entry into stationary phase | [ | |
| Valine | Intracellular level decreases in the stationary phase | [ | |
|
|
|
|
|
| Acetylphenylalanine | Accumulation in media at the beginning of stationary phase. Known to be detrimental to cell growth | [ | |
| Dimethylarginine | Accumulation in media at the beginning of stationary phase. By-product of protein degradation and can induce apoptosis | [ | |
| N-formimino-L-glutamate | Accumulation in media as culture enters stationary phase. Metabolite of the degradation of histidine or glutamate | [ | |
| Ammonia | Accumulation in media | [ | |
| Ammonium | Intracellular and media accumulation mainly due to breakdown of glutamine and several amino acids; has detrimental effects on growth presumably due to apoptosis induction | [ |
Amino acids and amino acids derivatives at the decline phase.
| Amino Acid | Behavior | Reference | Comments |
|---|---|---|---|
| Alanine | Accumulation in extracellular media after addition of anti-apoptotic agent | [ | |
| Arginine | NA | ||
| Asparagine and aspartic acid | Depleted from extracellular media after addition of anti-apoptotic agent | [ | The asparagine and aspartic acid concentrations used in these studies might be different, leading to their exhaustion at different times of the culture |
| Intracellular concentration decreases compared to other growth phases | [ | ||
| Depletion during stationary phase | [ | ||
| Cysteine | NA | ||
| Glutamine | NA | ||
| Glutamic acid | Accumulation in extracellular media after addition of anti-apoptotic agent | [ | The glutamic acid concentration used in these studies might be different, leading to its exhaustion at different times of the culture |
| Decreased intracellular concentration compared to other growth phases | [ | ||
| Glycine | NA | ||
| Histidine and isoleucine | Extracellular concentration decreases after addition of anti-apoptotic agent | [ | |
| Leucine | Exhaustion at entry into decline phase | [ | |
| Lysine | Extracellular concentration decreases after addition of anti-apoptotic agent. | [ | The glutamic acid concentration used in these studies might be different, leading to its exhaustion at different times of the culture |
| Exhaustion at entry into decline phase | [ | ||
| Detected; indicates over-supply | [ | ||
| Methionine and phenylalanine | Extracellular concentration decreases after addition of anti-apoptotic agent | [ | |
| Proline | NA | ||
| Serine | Extracellular concentration decreases after addition of anti-apoptotic agent | [ | The glutamic acid concentration used in these studies might be different, leading to its exhaustion at different times of the culture |
| Exhaustion at entry into decline phase | [ | ||
| Intracellular concentration decreases compared to other growth phases | [ | ||
| Threonine, tryptophan, tyrosine, valine | Extracellular concentration decreases after addition of anti-apoptotic agent | [ | |
| Ornithine | Detected. Known to have apoptotic properties | [ | |
|
|
|
|
|
| Pyroglutamate | Extracellular concentration increases after addition of anti-apoptotic agent | [ | |
| 4-hydroxyproline | Extracellular concentration decreases after addition of anti-apoptotic agent | [ | |
| Dimethylarginine, flutamylphenylalanine, glycerophosphocholine, hexanoglycine | Caspase activity increases after exposition of cells to these metabolites | [ |